NCT02063685 2022-06-21
Study to Evaluate the Efficacy of Response-adapted Strategy in Follicular Lymphoma
Fondazione Italiana Linfomi - ETS
Phase 3 Completed
Clinical Trials
4 trialsNCT01039376 2019-07-30
PROLONG
Novartis
Phase 3 Terminated
NCT00921414 2018-04-27
Mantel Cell Lymphoma Efficacy of Rituximab Maintenance
French Innovative Leukemia Organisation
Phase 3 Completed
NCT03016000 2017-07-28
Thalidomide Maintenance Treatment in DLBCL
Nanfang Hospital, Southern Medical University
Phase 3 Unknown